HOME
WESTCHESTER
FAIRFIELD
E-EDITIONS
Fairfield County
Westchester County
Supplements
INDUSTRIES
Real Estate
Economic Development
Hudson Valley
Courts
Banking & Finance
Construction
Economy
Education
Health Care
Food & Beverage
Government
Mergers & Acquisitions
Nonprofits
Retail
Small Business
Technology
FEATURES
Exclusives
Food & Restaurants
Travel
Health & Fitness
Home & Design
Good Things Happening
VIDEOS
EVENTS
Forty Under 40
Real Estate
Past Events
Literacy Luncheon
Women In Power
2022 Millennial + GenZ Awards
2022 C-Suite Awards
2022 Doctors of Distinction
2022 FORTY UNDER 40
2022 THE FUTURE OF REAL ESTATE
2021 Milli + GenZ Awards
2021 DOCTORS OF DISTINCTION
2021 C-SUITE
2021 TOP WEALTH ADVISORS Virtual Event
2021 FORTY UNDER 40 VIRTUAL EVENT
Events Calendar
MEMBERS
SUBSCRIBE
Search
Wednesday, March 29, 2023
Advertise
Contact
SIGN IN
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Westfair Communications
HOME
WESTCHESTER
FAIRFIELD
E-EDITIONS
Fairfield County
Westchester County
Supplements
INDUSTRIES
Real Estate
Economic Development
Hudson Valley
Courts
Banking & Finance
Construction
Economy
Education
Health Care
Food & Beverage
Government
Mergers & Acquisitions
Nonprofits
Retail
Small Business
Technology
FEATURES
Exclusives
Food & Restaurants
Travel
Health & Fitness
Home & Design
Good Things Happening
VIDEOS
EVENTS
Forty Under 40
Real Estate
Past Events
Literacy Luncheon
Women In Power
2022 Millennial + GenZ Awards
2022 C-Suite Awards
2022 Doctors of Distinction
2022 FORTY UNDER 40
2022 THE FUTURE OF REAL ESTATE
2021 Milli + GenZ Awards
2021 DOCTORS OF DISTINCTION
2021 C-SUITE
2021 TOP WEALTH ADVISORS Virtual Event
2021 FORTY UNDER 40 VIRTUAL EVENT
Events Calendar
MEMBERS
SUBSCRIBE
Home
Tags
MRSA
Tag: MRSA
Health Care
Yonkers drug developer ready for first human trials
John Golden
-
March 7, 2013
Contrafect Corp., a Yonkers-based biotechnology company, prepares to begin clinical trials on humans of its first bacteria-killing drug.
Don't miss the stories that matter most. Sign up for our free newsletter.
